Follow
Jiabi Zhang
Jiabi Zhang
Albert Einstein College of Medicine
Verified email at einsteinmed.edu
Title
Cited by
Cited by
Year
HIF-1α protects against oxidative stress by directly targeting mitochondria
HS Li, YN Zhou, L Li, SF Li, D Long, XL Chen, JB Zhang, L Feng, YP Li
Redox biology 25, 101109, 2019
2252019
Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: a systematic review and meta-analysis
J Shan, J Zhang
Joint Bone Spine 86 (2), 173-183, 2019
982019
Celastrol mediates Th17 and Treg cell generation via metabolic signaling
J Zhang, J Shan, X Chen, S Li, D Long, Y Li
Biochemical and biophysical research communications 497 (3), 883-889, 2018
352018
Rapamycin modulate Treg/Th17 balance via regulating metabolic pathways: a study in mice
J Zhang, H Jin, Y Xu, J Shan
Transplantation proceedings 51 (6), 2136-2140, 2019
202019
BMPER is a marker of adipose progenitors and adipocytes and a positive modulator of adipogenesis
JD Garritson, J Zhang, A Achenbach, M Ferhat, E Eich, CJ Stubben, ...
Communications Biology 6 (1), 638, 2023
62023
Correlates of chronic hepatitis B virus infection in the general adult population of China: Systematic review and meta‐analysis
EM Hamilton, W Rassam, Y Yan, A Singh, SYA Ng, J Zhang, J Lv, N Islam, ...
Journal of Viral Hepatitis 30 (6), 470-488, 2023
52023
Gas6/AXL pathway: immunological landscape and therapeutic potential
X Zhai, D Pu, R Wang, J Zhang, Y Lin, Y Wang, N Zhai, X Peng, Q Zhou, ...
Frontiers in Oncology 13, 1121130, 2023
32023
Ferroptosis in Cancer Immunity and Immunotherapy: Multifaceted Interplay and Clinical Implications
X Zhai, Y Lin, L Zhu, Y Wang, J Zhang, J Liu, L Li, X Lu
Cytokine & Growth Factor Reviews, 2023
22023
Landscape of adenosine pathway and immune checkpoint dual blockade in NSCLC: progress in basic research and clinical application
R Wang, Z Liu, T Wang, J Zhang, J Liu, Q Zhou
Frontiers in Immunology 15, 1320244, 2024
2024
Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib
X Zhai, T Wang, Y Lin, J Zhang, Y Wang, W Wang, Q Zhou, D Zhu
Frontiers in Oncology 13, 1104910, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–10